High throughput screening of normal and neoplastic tissue samples.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Combinatorial chemistry & high throughput screening

• Publication date

  2010-02-28

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/138620710790980540PMID 20015016
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification of a unique epigenetic sub‐microenvironment in prostate cancer

  2007cited by this paper
• CCR2 expression correlates with prostate cancer progression

  2007cited by this paper
• Genome-wide analysis of allelic imbalance in prostate cancer using the Affymetrix 50K SNP mapping array

  2007cited by this paper
• Global Expression Analysis of Prostate Cancer-associated Stroma and Epithelia

  2007cited by this paper
• Layered peptide array for multiplex immunohistochemistry.

  2007cited by this paper
• Distinctive gene expression of prostatic stromal cells cultured from diseased versus normal tissues

  2007cited by this paper
• Single nucleotide polymorphism array analysis of cancer

  2007cited by this paper
• The significance of LMO2 expression in the progression of prostate cancer

  2007cited by this paper
• Complementary techniques: laser capture microdissection--increasing specificity of gene expression profiling of cancer specimens.

  2007cited by this paper
• In situ identification of genes regulated specifically in fibroblasts of human basal cell carcinoma.

  2007cited by this paper
• BCAR1 expression in prostate cancer: Association with 16q23 LOH status, tumor progression and EGFR/KAI1 staining

  2007cited by this paper
• Layered expression scanning: multiplex molecular analysis of diverse life science platforms.

  2007cited by this paper
• Novel expressed sequences identified in a model of androgen independent prostate cancer

  2007cited by this paper
• Tumor-associated endothelial cells display GSTP1 and RARβ2 promoter methylation in human prostate cancer

  2006cited by this paper
• Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies

  2006cited by this paper
• Prostatic tissue protein alterations due to delayed time to freezing

  2006cited by this paper
• Elevated E2F1 inhibits transcription of the androgen receptor in metastatic hormone-resistant prostate cancer.

  2006cited by this paper
• Gene promoter methylation in prostate tumor-associated stromal cells.

  2006cited by this paper
• CD4+CD25high T Cells Are Enriched in the Tumor and Peripheral Blood of Prostate Cancer Patients1

  2006cited by this paper
• Identity crisis: finding, defining, and integrating biomarkers still a challenge.

  2006cited by this paper
• A molecular correlate to the Gleason grading system for prostate adenocarcinoma.

  2006cited by this paper
• Monocyte chemotactic protein‐1 (MCP‐1) acts as a paracrine and autocrine factor for prostate cancer growth and invasion

  2006cited by this paper
• DHT and testosterone, but not DHEA or E2, differentially modulate IGF-I, IGFBP-2, and IGFBP-3 in human prostatic stromal cells.

  2006cited by this paper
• Analysis of individual data from bead‐based assays (“bead arrays”)

  2006cited by this paper
• Nanoliter high throughput quantitative PCR

  2006cited by this paper
• Direct quantification of gene expression in homogenates of formalin-fixed, paraffin-embedded tissues.

  2006cited by this paper
• Biorepository and Biospecimen Science: A New Focus for CEBP

  2006cited by this paper
• Microfluidic enzyme-linked immunosorbent assay technology.

  2006cited by this paper
• Applying the SAGE technique to study the effects of electromagnetic field on biological systems

  2006cited by this paper
• An oligonucleotide microarray for high-throughput sequencing of the mitochondrial genome.

  2006cited by this paper
• E-cadherin protein expression predicts prostate cancer salvage radiotherapy outcomes.

  2006cited by this paper
• Expression of Novel Molecules, MICAL2-PV (MICAL2 Prostate Cancer Variants), Increases with High Gleason Score and Prostate Cancer Progression

  2006cited by this paper
• Expression of Ki-67, cyclin D1 and apoptosis markers correlated with survival in prostate cancer patients treated by radical prostatectomy.

  2006cited by this paper
• Evaluation of DNA microarray results with quantitative gene expression platforms

  2006cited by this paper
• Calixarene derivative as a tool for highly sensitive detection and oriented immobilization of proteins in a microarray format through noncovalent molecular interaction

  2005cited by this paper
• High‐resolution array comparative genomic hybridization of chromosome arm 8q: Evaluation of genetic progression markers for prostate cancer

  2005cited by this paper
• Bias as a threat to the validity of cancer molecular-marker research

  2005cited by this paper
• NMD Microarray Analysis for Rapid Genome-Wide Screen of Mutated Genes in Cancer

  2005cited by this paper
• Small Interfering RNA and Gene Expression Analysis Using a Multiplex Branched DNA Assay without RNA Purification

  2005cited by this paper
• Cell-cycle-associated markers and clinical outcome in human epithelial cancers: a tissue microarray study.

  2005cited by this paper
• Molecular Alterations in Primary Prostate Cancer after Androgen Ablation Therapy

  2005cited by this paper
• Tissue microarray analysis of hMSH2 expression predicts outcome in men with prostate cancer.

  2005cited by this paper
• Lessons from controversy: ovarian cancer screening and serum proteomics.

  2005cited by this paper
• Macrodissection versus microdissection of rectal carcinoma: minor influence of stroma cells to tumor cell gene expression profiles

  2005cited by this paper
• Activation of Signal Transducer and Activator of Transcription-5 in Prostate Cancer Predicts Early Recurrence

  2005cited by this paper
• Reduced alpha- and beta-catenin expression predicts shortened survival in local prostate cancer.

  2005cited by this paper
• Tissue microarrays: bridging the gap between research and the clinic

  2005cited by this paper
• A genome-wide scalable SNP genotyping assay using microarray technology

  2005cited by this paper
• Signal in noise: evaluating reported reproducibility of serum proteomic tests for ovarian cancer.

  2005cited by this paper
• Layered peptide arrays: high-throughput antibody screening of clinical samples.

  2005cited by this paper
• Reliable high-throughput genotyping and loss-of-heterozygosity detection in formalin-fixed, paraffin-embedded tumors using single nucleotide polymorphism arrays.

  2005cited by this paper
• Genome-wide screening for genetic changes in a matched pair of benign and prostate cancer cell lines using array CGH

  2005cited by this paper
• Importance of communication between producers and consumers of publicly available experimental data.

  2005cited by this paper
• An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays.

  2004cited by this paper
• A tiling resolution DNA microarray with complete coverage of the human genome

  2004cited by this paper
• Genotyping over 100,000 SNPs on a pair of oligonucleotide arrays

  2004cited by this paper
• Protein Profiling of Microdissected Prostate Tissue Links Growth Differentiation Factor 15 to Prostate Carcinogenesis

  2004cited by this paper
• Tracking cell signaling protein expression and phosphorylation by innovative proteomic solutions.

  2004cited by this paper
• Protein Profiling in Brain Tumors Using Mass Spectrometry

  2004cited by this paper
• Comparison of snap freezing versus ethanol fixation for gene expression profiling of tissue specimens.

  2004cited by this paper
• Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments

  2004cited by this paper
• High-resolution analysis of DNA copy number using oligonucleotide microarrays.

  2004cited by this paper
• Decoding randomly ordered DNA arrays.

  2004cited by this paper
• Rules of evidence for cancer molecular-marker discovery and validation

  2004cited by this paper
• Proteomics to diagnose human tumors and provide prognostic information.

  2004cited by this paper
• Expression Microdissection: Operator-Independent Retrieval of Cells for Molecular Profiling

  2004cited by this paper
• High‐throughput screening of genome fragments bound to differentially acetylated histones

  2004cited by this paper
• Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease

  2003cited by this paper
• Molecular Differentiation of High- and Moderate-Grade Human Prostate Cancer by cDNA Microarray Analysis

  2003cited by this paper
• Signal pathway profiling of ovarian cancer from human tissue specimens using reverse‐phase protein microarrays

  2003cited by this paper
• Protein microarrays: meeting analytical challenges for clinical applications.

  2003cited by this paper
• Genome-wide detection of LOH in prostate cancer using human SNP microarray technology.

  2003cited by this paper
• Proteomic patterns of tumour subsets in non-small-cell lung cancer.

  2003cited by this paper
• Protein microarrays: Molecular profiling technologies for clinical specimens

  2003cited by this paper
• Advantages and limitations of microarray technology in human cancer

  2003cited by this paper
• Proteomic approaches to the diagnosis, treatment, and monitoring of cancer.

  2003cited by this paper
• Signal pathway profiling of prostate cancer using reverse phase protein arrays

  2003cited by this paper
• Genome-wide loss of heterozygosity analysis from laser capture microdissected prostate cancer using single nucleotide polymorphic allele (SNP) arrays and a novel bioinformatics platform dChipSNP.

  2003cited by this paper
• High-resolution analysis of paraffin-embedded and formalin-fixed prostate tumors using comparative genomic hybridization to genomic microarrays.

  2003cited by this paper
• Layered expression scanning: multiplex analysis of RNA and protein gels.

  2003cited by this paper
• Protein arrays: The current state‐of‐the‐art

  2003cited by this paper
• Protein chip technology.

  2003cited by this paper
• ProteoChip: A highly sensitive protein microarray prepared by a novel method of protein immobilization for application of protein‐protein interaction studies

  2003cited by this paper
• Evaluation of ethanol‐fixed, paraffin‐embedded tissues for proteomic applications

  2003cited by this paper
• Evaluation of non-formalin tissue fixation for molecular profiling studies.

  2002cited by this paper
• Gene expression correlates of clinical prostate cancer behavior.

  2002cited by this paper
• Why is prostate cancer screening so common when the evidence is so uncertain? A system without negative feedback.

  2002cited by this paper
• Post-analysis follow-up and validation of microarray experiments

  2002cited by this paper
• Characterization of epithelial senescence by serial analysis of gene expression: identification of genes potentially involved in prostate cancer.

  2002cited by this paper
• Direct profiling and imaging of peptides and proteins from mammalian cells and tissue sections by mass spectrometry

  2002cited by this paper
• Protein microarrays and proteomics

  2002cited by this paper
• Identification and characterization of genes involved in the carcinogenesis of human squamous cell cervical carcinoma

  2002cited by this paper
• Optimized sample preparation for tandem capillary electrophoresis single-stranded conformational polymorphism/ heteroduplex analysis.

  2002cited by this paper
• Gene expression analysis of prostate cancers

  2002cited by this paper
• Identification of genes over-expressed in small cell lung carcinoma using suppression subtractive hybridization and cDNA microarray expression analysis

  2002cited by this paper
• Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ionization mass spectrometry.

  2002cited by this paper
• Serum proteomic patterns for detection of prostate cancer.

  2002cited by this paper
• Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer.

  2001cited by this paper
• Protein microarrays: prospects and problems.

  2001cited by this paper
• Tissue Microarray Profiling of Cancer Specimens and Cell Lines: Opportunities and Limitations

  2001cited by this paper

• High-throughput fluorescence quantification method based on inner filter effect and fluorescence imaging analysis.

  2024cites this paper
• Improving the Sensitivity of Molecular Diagnostics Assays

  2014cites this paper
• The osteopontin tissue level as a breast cancer biomarker in females after mastectomy measured by the capillary gel electrophoresis technique.

  2013cites this paper
• Advanced assessment of the endogenous hormone level as a potential biomarker of the urogenital tract cancer.

  2013cites this paper
• Measuring molecular biomarkers in epidemiologic studies: laboratory techniques and biospecimen considerations

  2012cites this paper
• OPLS-DA as a suitable method for selecting a set of gene transcripts discriminating RAS- and PTPN11-mutated cells in acute lymphoblastic leukaemia.

  2011cites this paper
• COLD-PCR: improving the sensitivity of molecular diagnostics assays

  2011cites this paper